COMP <GO>
ASPN vs PG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Aspen Aerogels Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: ASPN 0
— PG 11
■ METRIC PARITY
LAST: $5.05 (-6.31%) • MKT CAP: $447.3M
options-implied-move
—
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASPN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASPN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.00% | 51.20% | -34.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.40% | -60.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.02% | 3.77% | -4.79 | PG | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.30% | -84.30 | PG | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 19.00% | -79.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -40.10% | 0.30% | -40.40 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 60.3 | -9.90 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $447.3M | $372.21B | -$371.77B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASPN REV | PG REV | ASPN GROSS % | PG GROSS % | ASPN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $271.1M | $84.28B | 17.0% | 51.2% | -$4.6M | $14.04B |
| FY 2024 | $452.7M | $84.04B | 40.4% | 51.4% | -$40.7M | $16.52B |
| FY 2023 | $238.7M | $82.01B | — | — | -$42.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASPN // BETA —
PG // BETA 0.87